Justin Kupec is a Gastroenterology physician affiliated with West Virginia University. OpenAlex indexes 110 publications with 1,091 citations (h-index 15); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Wedgewood Dr
Suite 202
Morgantown, WV 265052442
Telephone
304-599-1448Provider last certified this registry record 8 Apr 2022.
Clinical trials
- Monitoring Vital Signs With a Wireless Ingestible Device in Subjects Undergoing Polysomnography
Sponsor: Celero Systems, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20251 payment
- PFIZER INC.Program year20251 payment
- Janssen Biotech, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
72.6%Proton pump inhibitor26.5%Omeprazole51%Pantoprazole Sodium31%Esomeprazole Magnesium9%Dexlansoprazole Dr9%Part D<11 patientsAminosalicylate10.8%Mesalamine40%Mesalamine Er35%Sulfasalazine25%Part D<11 patients+ 7 more classes in this area
Cancer & immunology
11%Purine Antimetabolite5.2%Azathioprine100%Part D<11 patientsTNF inhibitor2.9%Humira(Cf) Pen100%Part D<11 patients+ 1 more class in this area
Blood & clotting
6.1%Solutions for parenteral nutrition6.1%Peg 3350-Electrolyte100%Part D≥27 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Rural Gastroenterologist Supply Within the United States: A Workforce Review from 2014 to 2025
Digestive Diseases and Sciences
2026 - Safety of Esophageal Dilation Procedures in Patients on Antithrombotic Therapy: A Propensity-Matched Cohort Study
The American Journal of Gastroenterology
2025 - S1467 Risk of Inflammatory Bowel Disease Complications in Obese Inflammatory Bowel Disease Patients on GLP-1 Therapy: A Large Multicenter Cohort Study
The American Journal of Gastroenterology
2024 - Validation of a Clinical Risk-based Classification System in a Large Nonalcoholic Fatty Liver Disease Real-world Cohort
Clinical Gastroenterology and Hepatology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Peter Konrad, MD, PhD
West Virginia University
Hassan Ramadan, MD
West Virginia University
Ashkan Emadi, MD, PhD
West Virginia University
George Sokos, DO
West Virginia University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”